The human genome project has revolutionized our understanding of the underlying mechanisms in psychiatric disease. It is now abundantly clear that neurobehavioral phenotypes are epigenetically controlled by noncoding RNAs (ncRNAs). The microRNA (miRNA) class of ncRNAs are ubiquitously expressed throughout the brain and govern all major neuronal pathways. The attractive therapeutic potential of miRNAs is underscored by their pleiotropic capacities, putatively targeting multiple pathways within a single neuron. Many psychiatric diseases stem from a multi-factorial origin, thus conventional drug targeting of single proteins may not prove most effective. In this exciting post-genome sequencing era, many new epigenetic targets are emerging for therapeutic investigation. Here we review the reported roles of miRNAs, as well as other ncRNA classes, in the pathology of psychiatric disorders; there are both common and unique ncRNA mechanisms that influence the various diagnoses. Collectively, these potent epigenetic regulators may clarify the disrupted signaling networks in psychiatric phenotypes.
Introduction
A groundbreaking paradigm shift, the discovery of noncoding RNAs (ncRNAs), established the conventional "one gene, one protein" model to be an oversimplified view of gene regulation. Numerous ncRNA classes are now implicated in central nervous system (CNS) functions; microRNAs (miRNAs), natural antisense transcripts (NATs) and long intergenic RNAs (LincRNAs) all have reported regulatory activities in the brain [1] [2] [3] [4] . While pleiotropic ncRNAs, including miRNAs, can target large numbers of genes and signaling pathways simultaneously 5, 6 , there are also ncRNAs, such as NATs 2 , which hybridize to a limited A subset of miRNAs mediate neuronal specification, maturation and function. The transition from neural stem cells (NSCs) to neural progenitors and ultimately to fully differentiated neurons is highly regulated by a complex interaction of miRNAs and other factors 24 . In general, let-7 26, 27 , miR-124 [28] [29] [30] and miR-9 31 are thought to reduce NSC proliferation and promote neuronal differentiation. It is typically held that miR-134 32 and miR-25 33 induce the proliferation and/or inhibit the differentiation of NSCs and neural progenitors. In parallel, miR-137 both decreases 34, 35 and increases 36, 37 NSC proliferation, either enhancing or opposing neuronal maturation. There is an intricate overlap and feedback occurring between these key miRNAs, mediated in part by their target genes. Notably, miRNAs may mediate neurogenesis throughout development from embryo to adult. Adult neurogenesis is reportedly decreased in neurodegenerative disease 38, 39 and depression 40 , and is modulated by antidepressant therapeutics 41 . Thus, the following discussions regarding miRNA pathways in psychiatric disorders (outlined in Table 1 ) may involve neurons derived at all stages of brain maturity.
DiGeorge syndrome, is the most common rare variant identified in schizophrenia, occurring in approximately one percent of patients 42 . Many children with 22q11.2 deletion syndrome have developmental delays and learning disabilities, with a substantially elevated risk of developing schizophrenia (30%) 43 . Though the 22q11.2 region contains 30 to 40 genes, many have not been well characterized; one notable gene is DiGeorge syndrome critical region gene 8 (DGCR8), an essential contributor to microRNA biogenesis 8 . Microdeletion of 22q11.2 in mice results in the downregulation of a cluster of miRNAs with corresponding changes in cognitive and behavioral functions 12 .
Of the common genetic variants enriched in patients with schizophrenia, there is a wellestablished signal at miR-137 and several of its target genes [44] [45] [46] . Schizophrenia patients with a miR-137 risk allele exhibit greater symptom severity 47 , significantly altered functional connectivity 48 , reduced white matter integrity, smaller hippocampi and larger lateral ventricles 49 . Functionally validated targets of miR-137 include such schizophrenia risk genes as CACNA1C 50 , TCF4 50 and ZNF804A 51 , while additional putative targets include ERBB4, GABRA1, GRIN2A, GRM5, GSK3B, NRG2, and HTR2C 52 . Overexpression of miR-137 in a human NSC line identified direct and indirect miR-137 targets in neural cells. While direct miR-137 targets were enriched for transcription factors and cell cycle genes, indirect targets included pathways enriched in schizophrenia genome wide association studies, particularly major histocompatibility complex, synapses, FMRP interacting RNAs and calcium channels 53 . More recently, the largest study of common variance identified 108 regions significantly associated with schizophrenia, including significant hits at miR-137 and miR-548 46 .
Post-mortem profiling of miRNA expression in the prefrontal cortex of schizophrenia patients identified a global increase in miRNA expression compared to control populations 54 . More specifically, although the mature and pre-miRNA species were increased (particularly of miR-181b and miR-26b), there was no significant difference in transcription of the source pri-miRNA. These results suggest that the changes were due to increased miRNA biogenesis rather than altered miRNA transcription. The authors further observed upregulated expression of Drosha and DGCR8, both of which are involved in primiRNA processing, and speculate this is the ultimate cause of aberrant miRNA levels. Additionally, human analyses have started to reveal a profile signature of miRNA dysregulation in peripheral tissues such as plasma and serum of schizophrenia patients. Intriguingly, plasma levels of miR-181b (discussed above) were found to predict response to antipsychotic treatment 55 ; correspondingly, miR-30e has also been postulated as a plasma biomarker of schizophrenia 56 .
NMDA-R signaling, one of the most consistently implicated pathways in schizophrenia, is strongly controlled by miR-219 57 . Notably, miR-219 is the most enriched miRNA in the human synapse, the most downregulated in cortical synaptosomes of schizophrenia patients 20 , and was dysregulated in cortical tissue from two patient cohorts 20, 54 . Moreover, neuronal inhibition of miR-219-5p in mice significantly altered the precipitation of schizophrenia behavior by NMDA-R antagonists 57 . Taken together, miR-219-5p actively mediates synaptic functions and the development of psychiatric phenotypes. NMDA-R also regulates miR-132 21, [58] [59] [60] [61] [62] [63] , which is implicated in learning and memory functions 21, 59 , long-term potentiation [58] [59] [60] [61] and neurotransmission 61 . miR-132 expression is repressed in mice with genetic disruption of the enzyme which produces the NMDA-R co-agonist Dserine 64 , and these D-serine deficient mice recapitulate some of the neurobehavioral and cognitive impairments presented in patients with schizophrenia. Expression of miR-132 was dysregulated in human cortical tissue from two schizophrenia datasets but those expression changes were in opposite directions 20, 21 ; it remains possible that miR-132 is disrupted in specific neuronal cell types or distinct subcellular regions of neurons in schizophrenia. Interestingly, the NMDA-R regulated transcripts miR-132 and miR-219-5p (discussed above) 65, 66 regulate circadian rhythm, which is frequently disrupted in schizophrenia and other psychiatric disorders 67 . In addition, a subset of other miRNAs also reportedly regulate circadian functions, including miRs -279, 142-3p, 185, 138, let-7b, 125a, 206 and 182 [68] [69] [70] [71] [72] [73] [74] [75] [76] . Indeed, miRNA regulators of NMDA-R signaling and circadian rhythm could yield new therapeutic targets for treatment of neurobehavioral deficits. miRNA expression is responsive to current therapeutics administered for bipolar disorder, which is known to share overlapping genetic links with schizophrenia 77 . In rats treated with either lithium or valproate, there are a cohort of miRNAs altered in the hippocampus, including let-7b, let-7c, miR-128a, miR-24a, miR-30c, miR-34a, miR-221 and miR-144 78 . Additionally, miR-134 is altered in the plasma of treated bipolar disorder patients 79 .
Valproate and lithium significantly modulate Brain-Derived Neurotrophic Factor (BDNF) levels, a critical regulator of neuronal homeostasis 80, 81 , which is itself regulated by both short and long ncRNAs [82] [83] [84] , such as miR-124a. Notably, miR-124a is linked to depressionrelated behaviors 83 , as discussed in the section below.
As more post-mortem datasets become publicly available, we believe that groups of consistently altered transcripts in schizophrenia and bipolar disorder will emerge and potentially converge. Combining multimodal SNP and exome sequencing genotype information with RNA and miRNA expression datasets will facilitate miRNA-mRNA correlations. Furthermore, in vivo studies will allow for comprehensive investigation of identified candidates. Arguably, some of the more persistent miRNA associations in schizophrenia to date implicate miR-137, miR-181b, and miR-219-5p (Table 1) .
Depression
There is accumulating evidence for significant contribution of miRNA mechanisms in mood disorders such as depression. In the prefrontal cortex of depressed subjects who had died by suicide 85 , 21 miRNAs were significantly down-regulated in the major depressive disorder (MDD) group. More miRNAs were down-regulated than upregulated, implying a global down-regulation of miRNA levels in MDD. Furthermore, almost half of the down-regulated miRNAs were transcribed by the same pri-miRNA gene transcripts (mir-142-5p and 142-3p; mir-494, 376a*, 496, and 369-3p; mir-23b, 27b and 24-1*; mir-34b* and 34c; mir-17* and 20a) or found within the same chromosomal region (mir-424 and 20b at Xq26.2-3, 377 kb apart; mir-142 and 301a at 17q22, 820 kb apart; mir-324-5p and 497 at 17p13.1, 205 kb apart), suggesting that the down-regulated miRNA expression may be due to decreased transcription. In addition, a set of 29 miRNAs formed an inter-connected network in the MDD group: let-7b, mir-132, 181b, 338-3p, 486-5p, and 650 were "hubs". A recent study of genotyping polymorphisms from three miRNA processing genes (DGCR8, AGO1, and GEMIN4) found that DGCR8 rs3757 was associated with increased risk of suicidal tendency and improvement response to antidepressant treatment, whereas AGO1 rs636832 showed decreased risk of suicidal tendency, suicidal behavior, and recurrence 86 . Thus, polymorphisms in miRNA processing genes may influence depression risk and treatment.
Molecular targets of anti-depressants frequently engage the transporters of serotonin, a monoamine neurotransmitter 87 . miRNAs regulate the serotonin transporter (SERT) and its response to serotonin reuptake inhibitor (SSRI) therapeutics. Specifically, SSRI antidepressant fluoxetine (Prozac) treatment in mice induces expression of miR-16 while repressing the miR-16 target SERT 88 . Notably, miR-16 mediates the depression-related behavior through precise control of neurogenesis 89 . Another SERT associated miRNA, miR-135, was found to control the onset of co-existing depression and anxiety symptoms in mice 90, 91 as well as the response to anti-depressant treatment 90, 91 .
Because of limited studies in depressed patients, it is difficult to pinpoint specific miRNAs consistently implicated in the pathogenesis of depression; nevertheless, miRNAs that influence BDNF, including miR-132 and miR-34, and neuroinflammation, such as the let-7 family 92 , may be highly relevant (Table 1) . Intriguingly, miR-124a repression of BDNF provokes depression-related behaviors 83 and significantly mediates neurogenesis. Future studies could investigate if current anti-depressant therapeutics signal through miR-124a or other disease-associated miRNAs to enhance adult hippocampal neurogenesis 40, 41, 93, 94 .
Stress, anxiety, and fear disorders
The link between ncRNAs and stress, anxiety, or fear related responses opens new avenues for therapeutic intervention 95 . While a range of genetic associations have been loosely implicated in Post-Traumatic Stress Disorder (PTSD) 96 , epigenetic factors likely play a defining role in disease progression. A panel of disrupted miRNAs in the blood of military veterans with active PTSD symptoms have been identified 97 ; these PTSD-associated miRNAs were significantly associated with immunological pathways, suggestive of their pathogenic mechanisms in the disorder. Indeed, abnormal systemic immune responses are routinely reported in stress-related conditions [98] [99] [100] , consistent with its regulation by the PTSD-linked miRNAs. Intriguingly, a few of the miRNA transcripts altered in the veterans suffering from PTSD, including miR-19b and miR-223, were also perturbed in the serum and amygdala of a PTSD animal model 101 .
Stress and anxiety, however, are not unique behaviors to PTSD and are provoked through many distinct triggers. Overexpression of miR-34c in the central amygdala elicited an anxiolytic-like effect in mice stressed through acute restraint 102 ; furthermore, miR-34c directly targets a key mediator of stress responses, the corticotropin releasing factor receptor type 1 (CRFR1) gene. Notably, miR-34a was recently reported to regulate fear related responses through Notch signaling in mice 103 . Although miR-34a didn't alter anxietyrelated parameters in the same manner as miR-34c, it is possible that the miR-34 family is central in behavioral manifestations.
In addition to the above mentioned miRNAs, miRs -608, 124a, 132, 330-3p, and 16 are also implicated in anxiety phenotypes through genetic associations or in vivo analyses [104] [105] [106] [107] [108] [109] . Specifically, miR-124 is linked to both anxiety and stress related behaviors through glucocorticoid and corticosteroid signaling, respectively 105, 110 . Moreover, ablation of the miRNA biogenesis enzyme Dicer in the central amygdala of mice provoked the onset of anxiety-like symptoms 102 . Mice with Dicer knockout specifically in dopaminoceptive neurons also exhibit behavioral changes, including ataxia as well as front and hind limb clasping 111 . These Dicer-related phenotypes may also be independent of neurodegenerative mechanisms 111 .
Human genetic linkage studies and animal models also revealed miRNA pathways in panic or fear responses. At least four miRNAs have single-nucleotide polymorphisms (SNPs) in miRNA sequences located within panic disorder associated genes, including miR-22, miR-138-2, miR-148a, and miR-488 112 . Furthermore, miR-128 expression is increased with the formation of fear-extinction memory in mice, which is the re-conditioning of the memory to overcome established fear behaviors 113 .
An individual's ability to cope with stress is critical in the development of MDD. There is contrasting miRNA expression between rats who developed learned helpless (LH), a behavior that resembles stress-induced depression, compared to rats who did not develop depression (non-learned helpless [NLH]) in spite of receiving similar inescapable shocks 114 . One set of miRNAs showed large, significant, and consistent down-regulation in the frontal cortex of NLH rats compared to a blunted response in LH rats (miR-96, miR-141, miR-182, miR-183, miR-183*, miR-198, miR-200a, miR-200a*, miR-200b, miR-200b*, miR-200c, and miR-429). These synaptically enriched miRNAs 16 are encoded at a few shared polycistronic loci, suggesting coordinated control of their transcription, and they share 5′-seed motifs which indicate similar or overlapping sets of target mRNAs. Interestingly, half of this set are predicted to hit Creb1 as a target, and binding sites for CREB lie upstream of miR-96, miR-182, miR-183, miR-200a, miR-200b, miR-200c, miR-220a*, and miR-200b*. This suggests that a feedback loop arrangement may also exist between Creb and Creb-stimulated miRNAs and target genes 115 . Because these miRNAs are down regulated in NLH rats, but not LH rats, this can be interpreted as a homeostatic response intended to minimize repressive effects on Creb1.
Although more studies are needed to identify a list of miRNAs associated with stress, anxiety and fear, some putative candidates are emerging ( Table 1) . As discussed previously, miR19b and miR-223 were dysregulated in human and animal models of PTSD 97, 101 and should be evaluated further for therapeutic targeting in trauma-induced stress. Notably, these two transcripts share over 80 bioinformatic mRNA targets through Targetscan prediction. Additionally, the miR-34 family may exhibit an overlapping role in anxiety and fear responses 102, 103 . Overall, replication studies in human and animals will further define persistent miRNA mechanisms in these neurobehavioral deficits.
Long ncRNAs and the interaction between ncRNA transcripts in psychiatric disease
Although miRNAs are arguably the most extensively characterized class of ncRNA in neurons, long ncRNAs (lncRNA) are increasingly implicated in CNS functions 4, [116] [117] [118] . Long ncRNAs acts as miRNA sponges and can bind proteins and RNAs that regulate transcriptional changes and epigenetic modifications of chromatin. Indeed, these transcripts regulate basic neuronal biology as well as genes with strong disease-association 4, [116] [117] [118] [119] [120] [121] [122] . BC1, one of the first lncRNA transcripts characterized in the brain, is now known to modulate metabotropic receptor signaling 123, 124 . Select members of the NAT class of ncRNAs in the brain are functional and modulate expression of their sense partner 2, 82 ; NATs are endogenously transcribed and exhibit at least partial sequence complimentarity to protein-coding genes, ranging from short to long in nucleotide length 2 . An emerging area of investigation indicates that long and short neuronal ncRNAs are co-regulatory 125 , which is discussed more throughout the following sections. For example, the BACE1 gene linked to psychiatric and cognitive deficits in Alzheimer's Disease (AD)] is reportedly modulated by a network of competitive ncRNA interactions 126 . More specifically, it was shown that miR-485-5p binding sites in BACE1 are masked through a long antisense transcript, BACE1-AS 126 .
Evidence demonstrates that lncRNAs participate in neural plasticity, supported by the expression of a large number of these transcripts in dendrites 127 . In addition, a genomewide analysis show that lncRNAs are modulated by neuronal activity in human brain 128 . LncRNAs also mediate neurogenesis, neurodevelopment and related pathways 129, 130 . Reports suggest that fine-tuned regulatory control of the embryonic brain by these transcripts is required for development of mature CNS functions 130 . Mouse knockout studies involving long-intergenic ncRNAs (lincRNAs) found that loss of function for lincBrn1b results in a reduction of cerebral cortex progenitor cells and abnormal cortical lamination amongst other pathologies 3 . Furthermore, a subset of lincRNAs bind miRNAs and inhibit their functions (i.e. miRNA sponge), which can reportedly disrupt brain development 125 . Circular ncRNAs (circRNA) were also recently reported to function as miRNA sponges in neurons. For example, a circRNA was found to have multiple miRNA binding sites, including for miR-7, and both were co-expressed in neocortical and hippocampal neurons 131 . These studies further indicate the importance of interactions between ncRNAs in the brain and the need to uncover their epigenetic networks.
Neurotrophins, which play a key role in maintaining homeostatic activity in the CNS, reportedly respond to lncRNA signaling. For example, the neurotrophin BDNF has sequence complementarity with a conserved NAT, termed BDNF-AS. Functionally, BDNF-AS was reported to modulate neuronal growth in vitro and in vivo 82 . The sequence complementarity of this noncoding transcript appears to extend into the 3′ untranslated region (3′UTR) of BDNF, which contains regulatory miRNA binding sites such as miR-124a. miR-124, as discussed in previous sections, modulates depression and related neurobehavioral deficits; it is possible that the BDNF-AS partly functions by preventing miR-124 from binding to BDNF.
Susceptibility genes that precipitate psychiatric symptoms are also subject to lncRNA modulation. For example, an endogenous noncoding antisense transcript to the HTT gene (HTTAS) functionally regulates HTT expression 119 , which is the primary genetic aberration in HD and associated cognitive and neurobehavioral pathology. Susceptibility genes for schizophrenia are also epigenetically controlled by lncRNAs. Genetic variations in the Disrupted in Schizophrenia 1 (DISC1) gene are consistently linked with schizophreniaassociated behaviors 132, 133 . A recent report suggests the lncRNA Gomafu mediates DISC1 splicing events, resulting in splice variants linked to schizophrenia 134 . Gomafu, is implicated in neural development 129 and is downregulated in cortical tissue of schizophrenia patients and in activated human neuronal cells 134 . Additionally, DISC1 is regulated by its lncRNA antisense transcript DISC2 [120] [121] [122] 132 . Several groups have reported genetic association of DISC2 with schizophrenia as well as other psychiatric disorders [120] [121] [122] 132 ; however, DISC2 is not conserved among species 132 , hampering investigation of its regulatory mechanisms. One intriguing possibility is the existence of regulatory loop between DISC1 and the two ncRNA transcripts DISC2 and Gomafu.
Recent peripheral blood profiling studies also identified significant disruption of lncRNAs in depression, specifically patients with MDD, 17 of which were documented as depressionrelated gene in previous studies 135 . In parallel, this study uncovered potential miRNAmRNA networks that are consistent with genes previously associated with depression. Future studies could investigate co-regulatory mechanisms between the dysregulated miRNAs and lncRNAs in the disease. Additionally, the lncRNA antisense transcript coded by LOC285758 has been implicated in violent suicide completers 136 , likely triggered through depression or other psychiatric disorders.
Similar to miRNAs, it is possible some of the lncRNAs listed above may mediate the development of the distinct psychiatric symptoms through control of circadian genes. Global transcriptome profiling studies indicate that lncRNAs, including NATs, epigenetically regulate circadian biology 137, 138 . Indeed, an antisense RNA to a circadian gene in Neurospora, termed qrf, is regulated by light and represses the expression of its sense partner frq, through chromatin modifications 139 .
Summary
Regulating neural plasticity, neurogenesis, and numerous behavioral phenotypes, it is clear that ncRNAs contribute to the pathogenesis of many psychiatric disorders. Moreover, direct evidence comes from human postmortem brain and animal studies indicating perturbed ncRNA levels in disparate disease such as Huntington's, schizophrenia, depression, PTSD among others.
Despite these findings, one needs to find an integrated view of these ncRNA network(s). It is known that differential co-expression of distinct miRNA groups can directly mediate human disease pathogenesis as well as serve as a biomarker profile for disease diagnosis [140] [141] [142] [143] . The disrupted miRNAs, and their corresponding mRNA target genes in each psychiatric disease, are likely to interact with and regulate each other, both directly as targets and indirectly as part of larger regulatory networks. Furthermore, correlated miRNAs and mRNAs may be coordinately regulated by a (possibly overlapping) set of transcription factors or other epigenetic influences. It remains to be determined whether the changes in the miRNA/ mRNA network are i) similar or different across distinct brain regions ii) cell type-specific and iii) reversible mechanisms.
The underlying reasons for altered ncRNA expression remain unresolved and could result from a number of factors, including genetic changes in the promoter region or other locations within the gene. Additionally, defects in RNA editing or epigenetic suppression of the chromosomal region encoding the ncRNAs can also occur. Finally, miRNAs, lncRNAs, and their processing genes are susceptible to regulation by well-established signaling modulators such as BDNF, CREB, calcium, or calcium responsive neurotransmitters. For example, recently it was reported that Dicer is activated by proteolytic cleavage under conditions of elevated calcium levels 14, 16 . The networking of miRNAs and other ncRNAs into critical pathways such as neurotransmission, neurogenesis, and neurodevelopment may open up an entirely new understanding of psychiatric disease. Ultimately, we expect that for many of the complex psychiatric disorders we have considered, novel links between ncRNA mechanisms and the disease pathology will continue to emerge. Kocerha 
